Annual Total Assets
$117.22 M
-$17.05 M-12.70%
31 December 2023
Summary:
Rigel Pharmaceuticals annual total assets is currently $117.22 million, with the most recent change of -$17.05 million (-12.70%) on 31 December 2023. During the last 3 years, it has risen by +$6.85 million (+6.20%). RIGL annual total assets is now -62.19% below its all-time high of $310.04 million, reached on 31 December 2012.RIGL Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$139.42 M
+$11.01 M+8.58%
30 September 2024
Summary:
Rigel Pharmaceuticals quarterly total assets is currently $139.42 million, with the most recent change of +$11.01 million (+8.58%) on 30 September 2024. Over the past year, it has increased by +$24.09 million (+20.89%). RIGL quarterly total assets is now -55.03% below its all-time high of $310.04 million, reached on 31 December 2012.RIGL Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RIGL Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.7% | +20.9% |
| 3 y3 years | +6.2% | -25.3% |
| 5 y5 years | -15.7% | -10.7% |
RIGL Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -29.9% | +6.2% | -25.3% | +20.9% |
| 5 y | 5 years | -29.9% | +6.2% | -35.5% | +26.3% |
| alltime | all time | -62.2% | +582.8% | -55.0% | +326.7% |
Rigel Pharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $139.42 M(+8.6%) |
| June 2024 | - | $128.41 M(+1.5%) |
| Mar 2024 | - | $126.52 M(+7.9%) |
| Dec 2023 | $117.22 M(-12.7%) | $117.22 M(+1.6%) |
| Sept 2023 | - | $115.32 M(-1.5%) |
| June 2023 | - | $117.09 M(-5.3%) |
| Mar 2023 | - | $123.61 M(-7.9%) |
| Dec 2022 | $134.28 M(-19.8%) | $134.28 M(+16.1%) |
| Sept 2022 | - | $115.61 M(-9.7%) |
| June 2022 | - | $128.00 M(-14.1%) |
| Mar 2022 | - | $149.07 M(-10.9%) |
| Dec 2021 | $167.33 M(+51.6%) | $167.33 M(-10.3%) |
| Sept 2021 | - | $186.52 M(-7.5%) |
| June 2021 | - | $201.60 M(-6.7%) |
| Mar 2021 | - | $215.99 M(+95.7%) |
| Dec 2020 | $110.38 M(-25.2%) | $110.38 M(-10.3%) |
| Sept 2020 | - | $123.06 M(-10.9%) |
| June 2020 | - | $138.03 M(-3.7%) |
| Mar 2020 | - | $143.36 M(-2.9%) |
| Dec 2019 | $147.57 M(+6.1%) | $147.57 M(-5.4%) |
| Sept 2019 | - | $156.06 M(-0.1%) |
| June 2019 | - | $156.16 M(-9.6%) |
| Mar 2019 | - | $172.78 M(+24.2%) |
| Dec 2018 | $139.11 M(+16.8%) | $139.11 M(+12.9%) |
| Sept 2018 | - | $123.17 M(-12.8%) |
| June 2018 | - | $141.22 M(+42.9%) |
| Mar 2018 | - | $98.81 M(-17.0%) |
| Dec 2017 | $119.11 M(+52.4%) | $119.11 M(+67.2%) |
| Sept 2017 | - | $71.25 M(-16.6%) |
| June 2017 | - | $85.48 M(-15.6%) |
| Mar 2017 | - | $101.33 M(+29.7%) |
| Dec 2016 | $78.13 M(-40.7%) | $78.13 M(-11.9%) |
| Sept 2016 | - | $88.64 M(-10.8%) |
| June 2016 | - | $99.32 M(-8.3%) |
| Mar 2016 | - | $108.28 M(-17.8%) |
| Dec 2015 | $131.75 M(-14.5%) | $131.75 M(-5.3%) |
| Sept 2015 | - | $139.17 M(-6.2%) |
| June 2015 | - | $148.35 M(-10.5%) |
| Mar 2015 | - | $165.69 M(+7.5%) |
| Dec 2014 | $154.13 M(-31.8%) | $154.13 M(-5.6%) |
| Sept 2014 | - | $163.22 M(-10.5%) |
| June 2014 | - | $182.43 M(-10.3%) |
| Mar 2014 | - | $203.29 M(-10.1%) |
| Dec 2013 | $226.06 M(-27.1%) | $226.06 M(-5.6%) |
| Sept 2013 | - | $239.54 M(-8.5%) |
| June 2013 | - | $261.67 M(-7.5%) |
| Mar 2013 | - | $282.94 M(-8.7%) |
| Dec 2012 | $310.04 M | $310.04 M(+59.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $194.32 M(-9.4%) |
| June 2012 | - | $214.36 M(-8.4%) |
| Mar 2012 | - | $233.91 M(-9.0%) |
| Dec 2011 | $257.11 M(+37.7%) | $257.11 M(-6.8%) |
| Sept 2011 | - | $275.87 M(-4.8%) |
| June 2011 | - | $289.87 M(+75.0%) |
| Mar 2011 | - | $165.67 M(-11.3%) |
| Dec 2010 | $186.69 M(+32.6%) | $186.69 M(-4.7%) |
| June 2010 | - | $195.91 M(-9.8%) |
| Mar 2010 | - | $217.15 M(+54.3%) |
| Dec 2009 | $140.74 M(-2.2%) | $140.74 M(-14.3%) |
| Sept 2009 | - | $164.29 M(+86.2%) |
| June 2009 | - | $88.22 M(-22.6%) |
| Mar 2009 | - | $114.03 M(-20.7%) |
| Dec 2008 | $143.86 M(+24.2%) | $143.86 M(-14.7%) |
| Sept 2008 | - | $168.58 M(-13.4%) |
| June 2008 | - | $194.68 M(-10.7%) |
| Mar 2008 | - | $218.03 M(+88.3%) |
| Dec 2007 | $115.79 M(+2.3%) | $115.79 M(-3.3%) |
| Sept 2007 | - | $119.68 M(-10.8%) |
| June 2007 | - | $134.16 M(+37.7%) |
| Mar 2007 | - | $97.45 M(-13.9%) |
| Dec 2006 | $113.24 M(-23.3%) | $113.24 M(-9.0%) |
| Sept 2006 | - | $124.37 M(-5.2%) |
| June 2006 | - | $131.22 M(-5.2%) |
| Mar 2006 | - | $138.47 M(-6.2%) |
| Dec 2005 | $147.67 M(+87.3%) | $147.67 M(+8.6%) |
| Sept 2005 | - | $136.02 M(+98.2%) |
| June 2005 | - | $68.63 M(-14.6%) |
| Mar 2005 | - | $80.38 M(+2.0%) |
| Dec 2004 | $78.82 M(+42.0%) | $78.82 M(-0.8%) |
| Sept 2004 | - | $79.48 M(-12.1%) |
| June 2004 | - | $90.39 M(-11.6%) |
| Mar 2004 | - | $102.28 M(+84.2%) |
| Dec 2003 | $55.52 M(+25.2%) | $55.52 M(-16.5%) |
| Sept 2003 | - | $66.49 M(-1.1%) |
| June 2003 | - | $67.25 M(+105.8%) |
| Mar 2003 | - | $32.68 M(-26.3%) |
| Dec 2002 | $44.34 M(-4.5%) | $44.34 M(-17.6%) |
| Sept 2002 | - | $53.83 M(-16.0%) |
| June 2002 | - | $64.06 M(-13.6%) |
| Mar 2002 | - | $74.16 M(+59.7%) |
| Dec 2001 | $46.45 M(-27.7%) | $46.45 M(-12.2%) |
| Sept 2001 | - | $52.88 M(-2.7%) |
| June 2001 | - | $54.33 M(-8.5%) |
| Mar 2001 | - | $59.40 M(-7.6%) |
| Dec 2000 | $64.26 M(+274.3%) | $64.26 M |
| Dec 1999 | $17.17 M | - |
FAQ
- What is Rigel Pharmaceuticals annual total assets?
- What is the all time high annual total assets for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals annual total assets year-on-year change?
- What is Rigel Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals quarterly total assets year-on-year change?
What is Rigel Pharmaceuticals annual total assets?
The current annual total assets of RIGL is $117.22 M
What is the all time high annual total assets for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high annual total assets is $310.04 M
What is Rigel Pharmaceuticals annual total assets year-on-year change?
Over the past year, RIGL annual total assets has changed by -$17.05 M (-12.70%)
What is Rigel Pharmaceuticals quarterly total assets?
The current quarterly total assets of RIGL is $139.42 M
What is the all time high quarterly total assets for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high quarterly total assets is $310.04 M
What is Rigel Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, RIGL quarterly total assets has changed by +$24.09 M (+20.89%)